It’s been a while since new glaucoma medications have been introduced. Recently the FDA approved two new glaucoma medications designed to reduce intraocular pressure through different mechanisms. These new drops are Rhopressa (by Aerie Pharmaceutical) and Vyzulta (by Bausch and Lomb). However, at this time, the non-insurance cost can be prohibitive at around 300-400 dollars per bottle per month. In time, these prices will come down and insurance companies will cover these medications. If your insurance covers these glaucoma medications, they should be the ones to be on.
